Abstract:Background & Aims: As important virological markers, serum hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA levels show large fluctuations among chronic hepatitis B patients. The aim of this study was to reveal the potential impact and mechanisms of amino acid substitutions in small hepatitis B surface proteins (SHBs) on serum HBsAg and HBV DNA levels.Methods: Serum samples from 230 untreated chronic hepatitis B patients with genotype C HBV were analyzed in terms of HBV DNA levels, serological markers of HBV infection and SHBs sequences. In vitro functional analysis of the identified SHBs mutants was performed.Results: Among 230 SHBs sequences, there were 39 (16.96%) sequences with no mutation detected (wild-type) and 191 (83.04%) with single or multiple mutations. SHBs consist of 226 amino acids, of which 104 (46.02%) had mutations in our study. Some mutations (e.g., sE2G, sL21S, sR24K, sT47A/K, sC69stop (sC69*), sL95W, sL98V, and sG145R) negatively correlated with serum HBsAg levels. HBsAg and HBV DNA levels from this group of patients had a positive correlation (r = 0.61, p<0.001). In vitro analysis showed that these mutations reduced extracellular HBsAg and HBV DNA levels by restricting virion secretion and antibody binding capacity. Virion secretion could be rescued for sE2G, sC69*, and sG145R by co-expression of wild-type HBsAg.Conclusion: The serum HBsAg levels were lower in untreated CHB patients with novel SHBs mutations outside the major antigenic region than those without mutations. Underlying mechanisms include impairment of virion secretion and lower binding affinity to antibodies used for HBsAg measurements.Lay summary: The hepatitis B surface antigen (HBsAg) is a major viral protein of the hepatitis B virus (HBV) secreted into patient blood serum and its quantification value serves as an important marker for the evaluation of chronic HBV infection and antiviral response. We found a few new amino acid substitutions in HBsAg associated with lower serum HBsAg and HBV DNA levels. These different substitutions might impair virion secretion, change the ability of HBsAg to bind to antibodies, or impact HBV replication. These could all result in decreased detectable levels of serum HBsAg. The factors affecting circulating HBsAg level and HBsAg detection are varied and caution is needed when interpreting clinical significance of serum HBsAg levels. Clinical trial number: NCT01088009. (C) 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Studies on the Mechanism and Clinical Significance of Low Immunogenicity of Hepatitis B Virus "a" Determinant 129leu Variant

Antigen Expression and DNA Immunization of 129leu and 145arg Variants of Hepatitis B Virus S Gene

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

A Novel Hepatitis B Virus Variant S 129 (gln?leu): Lack of Correlation Between Antigenicity and Immunogenicity

Presence of Valine at Position 27 of the Hepatitis B Virus Core Gene is Associated with Severe Liver Inflammation in Chinese Patients

Amino Acid Substitutions at Positions 122 and 145 of Hepatitis B Virus Surface Antigen (hbsag) Determine the Antigenicity and Immunogenicity of HBsAg and InfluenceIn VivoHBsAg Clearance

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Reduced Antigenicity of Naturally Occurring Hepatitis B Surface Antigen Variants with Substitutions at the Amino Acid Residue 126.

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

[Role of mutations on the "hepatitis B virus 'a' determinant hotpoint" to the efficacy of hepatitis B vaccine].

Effect of HBV G145R Mutation on the Antigenicity of S Protein and the Synthetic Peptide of "a" Determinant

Biological Significance of Amino Acid Substitutions in Hepatitis B Surface Antigen (hbsag) for Glycosylation, Secretion, Antigenicity and Immunogenicity of HBsAg and Hepatitis B Virus Replication

The Modulation of HBsAg Level by Si126t is Affected by Additional Amino Acid Substitutions in the S Region of HBV.

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients

Effect of Mutation Within the ‘a’ Determinant on the Antigenicity of Hepatitis B Surface Antigen

Comparing the immunogenicity of hepatitis B virus S gene variants by DNA immunization.

Mutations in the 'a' Determinant of Hepatitis B Surface Antigen among Chinese Infants Receiving Active Postexposure Hepatitis B Immunization.

Effects of Amino Acid Substitutions in Hepatitis B Virus Surface Protein on Virion Secretion, Antigenicity, HBsAg and Viral DNA.

Hepatitis B virus Surface gene mutants in immunoprophylaxis-failed infants from Southern China.

Characteristics of Amino Acid Substitutions Within the "a" Determinant Region of Hepatitis B Virus in Chronically Infected Patients with Coexisting HBsAg and Anti-Hbs.

Genetic variation and significance of hepatitis B surface antigen